Cargando…

Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)

INTRODUCTION: Hypertension is the most important modifiable risk factor for cardiovascular disease and a leading public health concern. OBJECTIVES: The primary aim was to compare sequential nephron blockade (SNB) versus dual renin-angiotensin system blockade (DRASB) plus bisoprolol in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cestario, Elizabeth do Espirito Santo, Vilela-Martin, Jose Fernando, Cosenso-Martin, Luciana Neves, Rubio, Tatiane Azevedo, Uyemura, Jessica Rodrigues Roma, da Silva Lopes, Valquiria, Fernandes, Letícia Aparecida Barufi, Bonalume Tacito, Lucia Helena, Moreno Junior, Heitor, Yugar-Toledo, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762262/ https://www.ncbi.nlm.nih.gov/pubmed/36545494 http://dx.doi.org/10.2147/VHRM.S383007

Ejemplares similares

Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized controlled trial
por: Cestário, Elizabeth do Espirito Santo, et al.
Publicado: (2018)

Predictive Factors for Target Organ Injuries in Hypertensive Individuals
por: Paz Landim, Manoel, et al.
Publicado: (2021)

Sequential nephron blockade with combined diuretics improves diastolic function in patients with resistant hypertension
por: Fouassier, David, et al.
Publicado: (2020)

Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
por: Fernandes, Leticia Aparecida Barufi, et al.
Publicado: (2016)

Evidence of Nonadherence in Cases of Pseudoresistant Hypertension
por: Zanatta, João Marcos de Menezes, et al.
Publicado: (2021)

The Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral and Central Hemodynamic Parameters on Resistant Hypertension: A Case Report
por: Giollo-Junior, Luiz Tadeu, et al.
Publicado: (2023)

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
por: Yugar-Toledo, Juan Carlos, et al.
Publicado: (2017)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Comparison of Nebivolol and Bisoprolol for Cardiovascular Mortality in Hypertensive Patients
por: Kumar, Ratan, et al.
Publicado: (2019)

Impaired flow-mediated dilation response and carotid intima-media thickness in patients with type 1 diabetes mellitus with a mean disease duration of 4.1 years
por: Tacito, Lúcia Helena Bonalume, et al.
Publicado: (2017)

Activation of RAAS Signaling Contributes to Hypertension in Aged Hyp Mice
por: Latic, Nejla, et al.
Publicado: (2022)

The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes
por: Yugar, Louise Buonalumi Tacito, et al.
Publicado: (2023)

Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial
por: Vilela-Martin, José Fernando, et al.
Publicado: (2016)

Developmental Origins and Nephron Endowment in Hypertension
por: Gurusinghe, Shari, et al.
Publicado: (2017)

Comparison of Effect of Nebivolol and Bisoprolol on Sexual Function of Hypertensive Female Patients
por: Kumar, Nomesh, et al.
Publicado: (2021)

Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension
por: Zeng, Weiwei, et al.
Publicado: (2021)

Hypothesis: Unrecognized actions of ENaC blockade in improving refractory-resistant hypertension and residual cardiovascular risk
por: Elijovich, Fernando, et al.
Publicado: (2020)

Central blockade of salusin β attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats
por: Li, Hong-Bao, et al.
Publicado: (2015)

Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients
por: Peters, Eva L., et al.
Publicado: (2021)

Adrenergic receptor blockade attenuates placental ischemia‐induced hypertension
por: Spradley, Frank T., et al.
Publicado: (2018)

Inflammatory cytokines are associated to lower glomerular filtration rate in patients with hypertensive crisis
por: Andrade, Days O., et al.
Publicado: (2022)

Pseudo and resistant hypertension: A chaotic perspective
por: Moreno, Heitor
Publicado: (2022)

Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations—a mini review
por: Yugar-Toledo, Juan Carlos, et al.
Publicado: (2023)

Acquired Resistance to Immune Checkpoint Blockade Therapies
por: Zhao, Xianda, et al.
Publicado: (2020)

Combinations using checkpoint blockade to overcome resistance
por: Morganti, Stefania, et al.
Publicado: (2020)

Bisoprolol therapy does not reduce right ventricular sympathetic activity in pulmonary arterial hypertension patients
por: Rijnierse, Mischa T., et al.
Publicado: (2020)

Effect of amlodipine versus bisoprolol in hypertensive patients on maintenance hemodialysis: A randomized controlled trial
por: Youssef, Ahmed Mohamed, et al.
Publicado: (2021)

Angiotensinogen Variants among Resistant Hypertensive Patients
por: Barbaro, Natalia Ruggeri, et al.
Publicado: (2014)

Effect of thoracic epidural blockade on hypoxia-induced pulmonary arterial hypertension in rats
por: YU, Shi-huan, et al.
Publicado: (2014)

Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection
por: Salah, Husam M., et al.
Publicado: (2020)

Effect of Renin-Angiotensin System Blockade on Mortality in Korean Hypertensive Patients with Proteinuria
por: Oh, Hyung Jung, et al.
Publicado: (2019)

What is the impact of endothelin receptor blockade on atrial remodeling in a hypertensive model?
por: Van Wagoner, David R.
Publicado: (2022)

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
por: Williams, Bryan, et al.
Publicado: (2015)

CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism
por: Romoli, Simone, et al.
Publicado: (2018)

Influence of Apolipoprotein E on the Lipid Profile and Postprandial Triglyceride Levels in Brazilian Postmenopausal Women With Artery Disease
por: Tácito, Lúcia Helena Bonalume, et al.
Publicado: (2017)

Complex formation constant of ferric ion with Gly, Pro-Hyp and Gly-Pro-Hyp
por: Zhi, Mingyu, et al.
Publicado: (2018)

Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance
por: Zheng, Wenxin, et al.
Publicado: (2016)

Effects of bisoprolol and cilazapril on the central retinal artery blood flow in patients with essential hypertension—preliminary results
por: Madej, Andrzej, et al.
Publicado: (2010)

Effect of angiotensin II blockade on central blood pressure and arterial stiffness in subjects with hypertension
por: Safar, Michel E
Publicado: (2010)

Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension
por: Alhusban, Ahmed, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j3rqi8bs8a1j12uou5gd873tos